Covid19, Morbidity, Multiple, Old Age; Debility
Conditions
Brief summary
The COVID-Age Brugmann study aims to identify the clinical predictors of mortality risk in older patients admitted to an acute care unit due to COVID-19
Detailed description
The COVID-19 disease has been shown to be associated to higher mortality risk and health adverse consequences. Despite of the fact that the SAR-COV2 virus has been shown that affects every populations, the negative impact is higher in older people, pointing this population as the most severely affected. The COVID-Age Brugmann study aims to identify if comorbidity, geriatric syndromes, and health issues at admission are associated to mortality risk in older patients admitted to an acute care unit due to COVID-19
Interventions
None listed
Sponsors
Brugmann University Hospital
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients aged 70 and older * Patients admitted to an acute care geriatric unit due to COVID-19 * Patients with COVID-19 by PCR, serology or CT scan suggestive of this disease
Exclusion criteria
* No other demographic or clinical
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| All-cause mortality during hospital admission (admission up to discharge time) | Through study completion, an average of one month. | Vital status was obtained from medical records |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of medical diseases and geriatric syndromes | Through study completion, an average of one month. | Clinical and demographical conditions, and geriatric syndromes |
Countries
Belgium
Outcome results
None listed